Over the next decade, nanotechnology has the potential to influence virtually every aspect of our lives, including our energy, food, water, buildings, and medicines. However, in order to realize this broad potential ? robust, cost-effective, regulatory-friendly manufacturing technologies will be required. Through its novel technology platform and expansive intellectual property, Liquidia is poised to be a leader in the development of nanotechnology-based healthcare products and a catalyst for the growth anticipated across this industry. Mission:?By leveraging fabrication techniques from the semiconductor industry, Liquidia has the ability to rapidly design and manufacture precisely engineered particles of virtually any size, shape, or composition. This unique ability to precisely engineer particles enables scientists to explore new product frontiers that, until now, have otherwise been out of reach.
1 to 50 Employees
TypeCompany - Public
Revenue$5 to $10 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded